The invention relates to novel compounds which bind to integrin receptors, their use as ligands of integrin receptors, in particular as ligands of the α
v
β
3
integrin receptor, and pharmaceutical preparations comprising these compounds.
本发明涉及新型化合物,其与整合素受体结合,作为整合素受体的
配体使用,特别是作为αvβ3整合素受体的
配体,并包括这些化合物的制药制剂。